The Use of Psychomotor Vigilance Testing in the Assessment of Pediatric Obstructive Sleep Apnea
PVT
1 other identifier
interventional
7
1 country
1
Brief Summary
Obstructive sleep apnea results in decreased attentiveness and response times in patients. The objective of this study is to quantify these consequences in pediatric OSA patients using an already established tool for examining the results of sleep deprivation and fragmentation: psychomotor vigilance testing. PVT has been used in children, but has not been studied in pediatric OSA patients. This study aims to employ PVT along the normal course of diagnosis and treatment of pediatric OSA patients in our clinical practice at Arkansas Children's Hospital. The investigators hypothesize that pediatric OSA patients will exhibit decreased PVT scoring when compared to children without OSA, and that PVT can be used to diagnose and monitor treatment outcomes in these patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2010
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2010
CompletedFirst Submitted
Initial submission to the registry
January 12, 2011
CompletedFirst Posted
Study publicly available on registry
January 13, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2011
CompletedResults Posted
Study results publicly available
June 12, 2020
CompletedMay 5, 2021
May 1, 2021
1.3 years
January 12, 2011
September 3, 2019
May 3, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of Participants Who Achieved Criteria of Obstructive Sleep Apnea in the PVT Assessment
Subjects with obstructive sleep apnea will be asked to participate in 3 sessions. Your child will be asked to complete some noninvasive tests at each session. These tests consist of Psychomotor Vigilance Task testing. A Psychomotor Vigilance Task (PVT) will measure your level of alertness and attentiveness. The PVT involves pressing a button after hearing a specific tone or seeing a flashing light. This test takes approximately 10 minutes to complete. The PVT testing will be done at the first clinic visit, then before any treatments, and finally after treatments have taken place. Outcome Measure is full completion of the PVT testing.
10-20 minutes each session, 3 sessions total
Secondary Outcomes (1)
Number of Participants Who Achieved Criteria of No Sleep Complaints in the PVT Assessment
10-20 minute session, 1 session
Study Arms (1)
Psychomotor Vigilance Testing
OTHERThe purpose of this study is to examine the use of psychomotor vigilance testing (PVT) as a tool in the diagnosis and prediction of pediatric obstructive sleep apnea. PVT simply involves responding to a light by pressing a button on a small handheld device. It is a simple measure of reaction time.
Interventions
The purpose of this study is to examine the use of psychomotor vigilance testing (PVT) as a tool in the diagnosis and prediction of pediatric obstructive sleep apnea. PVT simply involves responding to a light by pressing a button on a small handheld device. It is a simple measure of reaction time.
Eligibility Criteria
You may qualify if:
- Healthy pediatric patients ages 6-18 years old
- with symptoms of OSA (snoring, pauses in sleep breathing, restless sleep, frequent arousals, excellive daytime sleepiness, morning headaches)
- with physical exam findings consistent with adenotonsillar hypertrophy
- those identified as good candidates for adenotonsillectomy
- who are to undergo a polysomnogram as part of their preoperative work-up
You may not qualify if:
- History of attention deficit disorder, developmental delay, or mental retardation
- Children taking any neurotropic medications (including antiepileptics, antidepressives, and stimulants)
- Children previously treated for OSA (surgically or medically)
- Children with significant comorbidities including other sleep-related disorders
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Arkansas Children's Hospital
Little Rock, Arkansas, 72202, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Clinical Research Coordinator
- Organization
- Arkansas Children's Hospital
Study Officials
- PRINCIPAL INVESTIGATOR
Gresham T Richter, MD
UAMS, ACH
Publication Agreements
- PI is Sponsor Employee
- Yes
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 12, 2011
First Posted
January 13, 2011
Study Start
May 1, 2010
Primary Completion
September 1, 2011
Study Completion
September 1, 2011
Last Updated
May 5, 2021
Results First Posted
June 12, 2020
Record last verified: 2021-05